Franck Talmont is appointed Ambassador for Innovation at the CNRS
Dr. Franck Talmont has more than 30 years of expertise in the biochemical and pharmacological study of membrane proteins. A specialist in molecular pharmacology, he works in particular on membrane receptors involved in various pathologies: opioid and neuropeptide FF receptors (pain perception), sphingosine-1-phosphate receptors (multiple sclerosis), and NMDA receptors (neuropsychiatric and neurodegenerative diseases).
In 2021, he joined the Cellular Biophysics team at the IPBS to develop a project dedicated to the impact of electric and electromagnetic fields on the functioning of skin receptors, a project currently in Phase 2 of evaluation by ANSES.
Author of two patents, one of which was used to increase soybean productivity, he also filed a second patent in 2012. Following a collaboration with the company BIOTEM, a monoclonal antibody targeting the S1P1 receptor is now commercially available.
He is the scientific lead of the Trans-NMDA LabCom (CNRS – Rest Therapeutics), dedicated to the development of new drugs targeting post-traumatic stress disorder. He leads and coordinates a prematuration project currently under evaluation by CNRS Innovation for the development of new antidepressants. Finally, he serves as co-scientific and operational lead of the ANR InflamMAb LabCom project (IPBS – G.Clips Biotech), focused on the production of anti-inflammatory antibodies targeting membrane proteins.
The mission of the Ambassadors for Innovation is to share their experience as innovators in order to inspire others, among their colleagues, research staff in their laboratories, and more broadly within their geographic or thematic ecosystem, to engage in innovative activities.
To date, the network brings together around eighty researchers. It highlights the diversity of forms that innovation can take: participation in a technology transfer or valorization program, the creation of start-ups, industrial chairs, joint laboratories, and collaborative research contracts.
The network, still in its early stages, is set to expand and become more structured in 2026 in order to serve as a catalyst for innovation at the CNRS.